Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells by modulating PI3K/Akt pathway

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Xu, Xiaoman ^a   Zhang, Yi ^a   Qu, Dan ^a   Jiang, Tingshu ^a   Li, Shengqi ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; DNA; OSTHOLE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; CDC2 PROTEIN, HUMAN; COUMARIN DERIVATIVE; CYCLIN B; ONCOPROTEIN; PROTEIN BAD;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOASSAY; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; WESTERN BLOTTING; DRUG EFFECT; DRUG SCREENING; LUNG TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; COUMARINS; CYCLIN B; CYCLIN B1; DRUG SCREENING ASSAYS, ANTITUMOR; G2 PHASE; HUMANS; LUNG NEOPLASMS; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION;

EID: 79953084520     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-33     Document Type: Article

References (33)

1. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078 (Pubitemid 40372904)
2. Cancer statistics, 2008. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun, CA Cancer J Clin 2008 58 71 96 10.3322/CA.2007.0010 18287387 (Pubitemid 351521864)
3. International comparisons of survival from lung cancer: pitfalls and warnings. SC Erridge H Moller A Price D Brewster, Nat Clin Pract Oncol 2007 4 570 7 10.1038/ncponc0932 17898807 (Pubitemid 47534756)
4. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo. SC Hsu CC Ou TC Chuang JW Li YJ Lee V Wang JY Liu CS Chen SC Lin MC Kao, Cancer Lett 2009 281 108 16 10.1016/j.canlet.2009.02.032 19332363
5. Tanshinone IIA down-regulates the protein expression of ErbB-2 and up-regulates TNF-alpha in colon cancer cells in vitro and in vivo. CC Su YH Lin, Int J Mol Med 2008 22 847 51 19020785
6. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5. BZ Carter DH Mak WD Schober MF Dietrich C Pinilla LT Vassilev JC Reed M Andreeff, Blood 2008 111 3742 50 10.1182/blood-2007-05-091504 18187663
7. Antiproliferative effect in rat vascular smooth muscle cells by osthole, isolated from Angelica pubescens. JH Guh SM Yu FN Ko TS Wu CM Teng, Eur J Pharmacol 1996 298 191 7 10.1016/0014-2999(95)00812-8 8867108 (Pubitemid 26081888)
8. Vasorelaxation of rat thoracic aorta caused by osthole isolated from Angelica pubescens. FN Ko TS Wu MJ Liou TF Huang CM Teng, Eur J Pharmacol 1992 219 29 34 10.1016/0014-2999(92)90576-P 1327835
9. Immunomodulatory and anti-inflammatory activity of selected osthole derivatives. M Zimecki J Artym W Cisowski I Mazol M Wlodarczyk M Glensk, Z Naturforsch C 2009 64 361 8 19678539
10. Studies on the quality of fructus Cnidii - comparison of antibacterial action. J Cai B Yu G Xu J Wu, Zhongguo Zhong Yao Za Zhi 1991 16 451 3 510 1804179
11. Anti-allergic effects of cnidii monnieri fructus (dried fruits of Cnidium monnieri) and its major component, osthol. H Matsuda N Tomohiro Y Ido M Kubo, Biol Pharm Bull 2002 25 809 12 10.1248/bpb.25.809 12081154 (Pubitemid 40036723)
12. Inhibition of concanavalin A-induced mice hepatitis by coumarin derivatives. T Okamoto S Yoshida T Kobayashi S Okabe, Jpn J Pharmacol 2001 85 95 7 10.1254/jjp.85.95 11243581
13. Cytotoxic activity of coumarins from the fruits of Cnidium monnieri on leukemia cell lines. LL Yang MC Wang LG Chen CC Wang, Planta Med 2003 69 1091 5 10.1055/s-2003-45188 14750023
14. Antitumor effects of Osthol from Cnidium monnieri: an in vitro and in vivo study. SY Chou CS Hsu KT Wang MC Wang CC Wang, Phytother Res 2007 21 226 30 10.1002/ptr.2044 17154232
15. Effects of osthole on migration and invasion in breast cancer cells. D Yang T Gu T Wang Q Tang C Ma, Biosci Biotechnol Biochem 2010 74 1430 4 10.1271/bbb.100110 20622464
16. Antiproliferative effects of isopentenylated coumarins isolated from Phellolophium madagascariense Baker. C Riviere L Goossens N Pommery C Fourneau A Delelis JP Henichart, Nat Prod Res 2006 20 909 16 10.1080/14786410500277787 16854718 (Pubitemid 44144701)
17. Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas. T Okamoto T Kobayashi S Yoshida, Curr Med Chem Anticancer Agents 2005 5 47 51 10.2174/1568011053352622 15720260 (Pubitemid 40081293)
18. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. A Kauffmann-Zeh P Rodriguez-Viciana E Ulrich C Gilbert P Coffer J Downward G Evan, Nature 1997 385 544 8 10.1038/385544a0 9020362 (Pubitemid 27074674)
19. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. I Vivanco CL Sawyers, Nat Rev Cancer 2002 2 489 501 10.1038/nrc839 12094235 (Pubitemid 37328931)
20. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. NM Weir K Selvendiran VK Kutala L Tong S Vishwanath M Rajaram S Tridandapani S Anant P Kuppusamy, Cancer Biol Ther 2007 6 178 84 10.4161/cbt.6.2.3577 17218783 (Pubitemid 46641620)
21. Akt/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2/M transition. K Katayama N Fujita T Tsuruo, Mol Cell Biol 2005 25 5725 37 10.1128/MCB.25.13.5725-5737.2005 15964826 (Pubitemid 40853605)
22. Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt. L Asnaghi A Calastretti A Bevilacqua I D'Agnano G Gatti G Canti D Delia S Capaccioli A Nicolin, Oncogene 2004 23 5781 91 10.1038/sj.onc.1207698 15208671 (Pubitemid 39093023)
23. Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. CP Xavier CF Lima A Preto R Seruca M Fernandes-Ferreira C Pereira-Wilson, Cancer Lett 2009 281 162 70 10.1016/j.canlet.2009.02.041 19344998
24. Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 6-chloro-7-[corrected](2-morpholin-4-ylethylamino)-quinoline-5,8-dione. L Pu AA Amoscato ME Bier JS Lazo, J Biol Chem 2002 277 46877 85 10.1074/jbc.M207902200 12356752 (Pubitemid 36159191)
25. Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. JI Chao PC Kuo TS Hsu, J Biol Chem 2004 279 20267 76 10.1074/jbc.M312381200 14988404
26. Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy. Y Wang P Ji J Liu RR Broaddus F Xue W Zhang, Mol Cancer 2009 8 8 10.1186/1476-4598-8-8 19216791
27. Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity. BC Dash WS El-Deiry, Mol Cell Biol 2005 25 3364 87 10.1128/MCB.25.8.3364-3387.2005 15798220 (Pubitemid 40464336)
28. Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model. CJ Yang CS Wang JY Hung HW Huang YC Chia PH Wang CF Weng MS Huang, Lung Cancer 2009 66 162 8 10.1016/j.lungcan.2009.01.016 19233505
29. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. T Oltersdorf SW Elmore AR Shoemaker RC Armstrong DJ Augeri BA Belli M Bruncko TL Deckwerth J Dinges PJ Hajduk MK Joseph S Kitada SJ Korsmeyer AR Kunzer A Letai C Li MJ Mitten DG Nettesheim S Ng PM Nimmer JM O'Connor A Oleksijew AM Petros JC Reed W Shen SK Tahir CB Thompson KJ Tomaselli B Wang MD Wendt H Zhang SW Fesik SH Rosenberg, Nature 2005 435 677 81 10.1038/nature03579 15902208 (Pubitemid 40825512)
30. Specific alteration of the Bax/Bcl2 ratio and cytochrome c without execution of apoptosis in the hippocampus of aged baboons. S Thees GB Hubbard J Winckler C Schultz A Rami, Restor Neurol Neurosci 2005 23 1 9 15846027 (Pubitemid 40529557)
31. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. S Gupta F Afaq H Mukhtar, Oncogene 2002 21 3727 38 10.1038/sj.onc.1205474 12032841 (Pubitemid 34620536)
32. Targeted therapy against Bcl-2-related proteins in breast cancer cells. M Emi R Kim K Tanabe Y Uchida T Toge, Breast Cancer Res 2005 7 940 52 10.1186/bcr1323 16280040
33. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. J Luo BD Manning LC Cantley, Cancer Cell 2003 4 257 62 10.1016/S1535-6108(03) 00248-4 14585353 (Pubitemid 37329790)